AI
Google DeepMind’s AlphaGenome 2 aims to map DNA changes to disease
Nov 11, 2026 · Summarized by Fundy Tech from The Verge
The 30-second version
Google DeepMind unveiled AlphaGenome 2, a model that predicts how DNA changes affect different cell types and states. Google says it could help researchers spot disease-relevant effects earlier.
Key points
- AlphaGenome 2 follows last year’s AlphaGenome model.
- It was trained on more than 100 million cell profiles across 68 tissues.
- Google says it identifies nearly twice as many gene-expression-changing variants.
Why it matters
This is a research tool, not a consumer product. But better disease modelling can eventually shape treatments, diagnostics and the biotech products that reach hospitals and pharmacies.
Who’s affected: Researchers studying genetics and disease
What to do
- Follow research updates from DeepMind and partner labs.
- Watch for downstream biotech and treatment research.
- No immediate action needed for most readers.
Original reporting
Not sure if this affects you?
Fundy Tech helps businesses and households across Atlantic Canada stay patched, protected and up to speed. Tell us what you’re running and we’ll tell you straight whether you need to act.